Article
The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
7 Apr 2021
Abstract excerpt
Background Osteosarcoma (OTS) is aggressive bone malignancy without well-recognized prognosis biomarker. Tumor mutational burden (TMB) has been proved as effective biomarker in predicting clinical outcomes in several cancer types. However, its prognostic value in OTS remains unknown. In this study, we aim to evaluate the implication of TMB in OTS patients. Methods To depict the landscape of somatic mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
